Article
Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia
1 Apr 2001
Abstract excerpt
To identify new markers of minimal residual disease (MRD) in B-lineage acute lymphoblastic leukemia (ALL), gene expression of leukemic cells obtained from 4 patients with newly diagnosed ALL was compared with that of normal CD19(+)CD10(+) B-cell progenitors obtained from 2 healthy donors. By cDNA array analysis, 334 of 4132 genes studied were expressed 1.5- to 5.8-fold higher in leukemic cells relative to both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
